JYL BIOMEDICAL SERVICES LTD
Company number 13937667 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
JYL BIOMEDICAL SERVICES LTD - Analysis Report
Company Number: 13937667
Analysis Date: 2025-07-29 20:53 UTC
Risk Rating: MEDIUM
The company shows a moderate risk profile. While it remains active with no overdue filings, the latest financials reveal declining liquidity and net assets, indicating potential cash flow pressures. The micro-entity scale and limited employee base also suggest a small operational footprint with constrained resources.Key Concerns:
- Liquidity Decline: Net current assets dropped from £3,000 (2023) to a negative £250 (2024), signaling short-term liabilities exceeding current assets which may impede meeting immediate obligations.
- Reduced Net Assets: Total net assets decreased from £10,000 to £8,750, evidencing a slight erosion of equity possibly due to operational losses or asset disposals.
- Concentrated Control and Management: Single director and 100% ownership by Mr. Ibrahim Medani may pose governance and succession risks, particularly if the business faces operational challenges.
- Positive Indicators:
- Compliance: No overdue accounts or confirmation statements, indicating regulatory compliance and good standing with Companies House.
- Stable Ownership: Clear control structure with an identified person with significant control, facilitating decision-making and accountability.
- Operating Continuity: The company has maintained active status since incorporation in 2022 with ongoing filings and a consistent reporting framework under micro-entity provisions.
- Due Diligence Notes:
- Investigate the reasons behind the decrease in current assets and increase in current liabilities to assess cash flow and working capital management.
- Review the income statement and cash flow details (not provided) to understand profitability and operational cash generation.
- Evaluate any contingent liabilities or off-balance sheet risks not captured in the balance sheet.
- Consider assessing director’s plans for business growth, capitalization, and management continuity given the single-person governance structure.
- Confirm existence and valuation of fixed assets reported and any depreciation or impairment taken.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.